Microbiome Labs Expands Portfolio with Launch of Women’s Health Line
Franklinton, North Carolina--(Newsfile Corp. - October 29, 2025) - Microbiome Labs, a leader in microbiome-based solutions, today announced the launch...
Pregnancy
OMRON Healthcare Wins Best in Class in the 2025 Digital Health Awards at HLTH
Expert judges determining the best of the best in healthcare innovation recognized OMRON Healthcare for its blood pressure monitors with...
Desert Oasis Healthcare Expands Maternal Health Resources with New Maternal Health Educator Position and Updated Video Education Series
DOHC strengthens its commitment to mothers and families through expanded education and personalized prenatal support PALM SPRINGS, CALIFORNIA / ACCESS...
TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosing Schedule for BRIUMVI
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in...
Simbryo Technologies Introduces Personalized Assay to Help IVF Patients Avoid Repeated Failed Transfers
New diagnostic addresses critical gap in IVF care—measuring whether the uterus is ready to support an embryo Study shows test...
Simbryo Technologies Introduces Personalized Assay to Help IVF Patients Avoid Repeated Failed Transfers
New diagnostic addresses critical gap in IVF care—measuring whether the uterus is ready to support an embryo Study shows test...
Simbryo Technologies Introduces Personalized Assay to Help IVF Patients Avoid Repeated Failed Transfers
New diagnostic addresses critical gap in IVF care—measuring whether the uterus is ready to support an embryo Study shows test...
Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches
Brekiya® autoinjector, a new specialty therapy from Amneal, is now available for prescription exclusively through Walgreens Specialty Pharmacy and Sterling...
Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches
Brekiya® autoinjector, a new specialty therapy from Amneal, is now available for prescription exclusively through Walgreens Specialty Pharmacy and Sterling...
Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches
Brekiya® autoinjector, a new specialty therapy from Amneal, is now available for prescription exclusively through Walgreens Specialty Pharmacy and Sterling...
Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference
FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in...
Carrot Launches Carrot Rx ‘Flex Program’ For U.S Employers to Access Even More Cost Savings for Employees
Employers can now implement fertility pharmacy benefits with even more customization, maximizing access to price transparency and cost savings WEST...
Pacify and Community Care Plan Collaborate to Enhance Maternal Health Support Services
FORT LAUDERDALE, Fla., Oct. 21, 2025 /PRNewswire/ -- Pacify Health, a leading provider of a multimodal maternal health platform offering members...
Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2025 American College of Rheumatology (ACR) Convergence
CHATHAM, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated,...
MySwaddle Partners with Penfield Children’s Center to Transform Maternal Health Outcomes in Milwaukee
Digital maternal health platform brings comprehensive prenatal and postpartum support to pregnant women and families in Milwaukee community MILWAUKEE, Oct....
New Study Showed Unnecessary Burden From Continued Monitoring of Alloimmunized Pregnancies With Antigen-Negative Fetuses
New research demonstrates that monitoring with titers frequently leads to burdensome and unnecessary monitoring for pregnancies not at risk of...
60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study
Company engaged patients diagnosed with chronic babesiosis via social media in a nationwide naming competitionA $5K donation from the Company...
Tonix Pharmaceuticals to Present and Participate in Panel Discussion at World Vaccine Congress, Europe 2025
CHATHAM, N.J., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated...
NeoPredics Announces Market Launch of PreFree Across CE-Markets
- Clinical challenge: uncertainty in discharge and admission decisions for women at risk of preeclampsia- PreFree: the first CE-marked, multimodal...
From Fertility Myths to Menopause: Maven Clinic’s New Campaign Takes on What Sex Ed Missed
Interactive NYC pop-up on October 7 kicks off campaign to spark conversations about what people were never taught in school...